Search Results 811-820 of 1467 for 贵阳用友软件 www.w-t.cn
Monoclonal antibodies, such as atezolizumab, may block specific proteins found on white blood cells which may strengthen the immune system and control tumor ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB067 in participants with amyotrophic lateral sclerosis (ALS) and ...
The primary objective of this study is to describe the safety and toxicity of grid + immunotherapy in stage IV NSCLC using CTCAE v5.0. Participation eligibility.
Mayo Clinic's Infectious Diseases Laboratory, led by Robin Patel, M.D., focuses on microbial biofilms and antibacterial resistance.
The purpose of this study is to define the maximum tolerated dose (MTD)/recommended phase 2 dose (RP2D), safety profile, pharmacokinetics (PK), pharmacodynamics ...
About this study. This pilot study is designed to determine if the rehabilitative benefits of continuous passive motion (CPM) will help preserve/restore the ...
The purpose of this study is to assess the long-term safety and tolerability of CVL-865 as adjunctive therapy in participants with focal onset seizures.
Learn how doctors use innovative operations, such as transoral robotic surgery, and radiation technology, including protons, for tongue cancer treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each year.